Perinatal Mortality Despite Prenatal Diagnosis of Vasa Previa: A Systematic Review.


Journal

Obstetrics and gynecology
ISSN: 1873-233X
Titre abrégé: Obstet Gynecol
Pays: United States
ID NLM: 0401101

Informations de publication

Date de publication:
01 09 2023
Historique:
received: 04 04 2023
accepted: 01 06 2023
medline: 21 8 2023
pubmed: 3 8 2023
entrez: 3 8 2023
Statut: ppublish

Résumé

To determine the causes and potential preventability of perinatal deaths in prenatally identified cases of vasa previa. Reports of prenatally identified cases of vasa previa published in the English language literature since 2000 were identified in Medline and ClinicalTrials.gov with the search terms "vasa previa," "abnormal cord insertion," "velamentous cord," "marginal cord," "bilobed placenta," and "succenturiate lobe." All cases from the above search with an antenatally diagnosed vasa previa present at delivery in singleton or twin gestations with perinatal mortality information were included. Cases meeting inclusion criteria were manually abstracted, and multiple antenatal, intrapartum, and outcome variables were recorded. Deaths and cases requiring neonatal transfusion were analyzed in relation to plurality, routine hospitalization, and cervical length monitoring. A total of 1,109 prenatally diagnosed cases (1,000 singletons, 109 twins) were identified with a perinatal mortality rate attributable to vasa previa of 1.1% (95% CI 0.6-1.9%). All perinatal deaths occurred with unscheduled deliveries. The perinatal mortality rate in twin pregnancies was markedly higher than that in singleton pregnancies (9.2% vs 0.2%, P <.001), accounting for 80% of overall mortality despite encompassing only 9.8% of births. Compared with individuals with singleton pregnancies, those with twin pregnancies are more likely to undergo unscheduled delivery (56.4% vs 35.1%, P =.01) despite delivering 2 weeks earlier (33.2 weeks vs 35.1 weeks, P =.006). An institutional policy of routine hospitalization is associated with a reduced need for neonatal transfusion (0.9% vs 6.0%, P <.001) and a reduction in the perinatal mortality rate in twin pregnancies (0% vs 25%, P =.002) but not in singleton pregnancies (0% vs 0.5%, P =.31). Routine hospitalization and earlier delivery of twins may result in a reduction in the perinatal mortality rate. A smaller benefit from routine admission of individuals with singleton pregnancies cannot be excluded. There is currently insufficient evidence to recommend the routine use of cervical length measurements to guide clinical management.

Identifiants

pubmed: 37535966
doi: 10.1097/AOG.0000000000005296
pii: 00006250-990000000-00832
doi:

Types de publication

Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

519-528

Informations de copyright

Copyright © 2023 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

Financial Disclosure The author did not report any potential conflicts of interest.

Références

Zhang W, Geris S, Al-Emara N, Ramadan G, Sotiriadis A, Akolekar R. Perinatal outcome of pregnancies with prenatal diagnosis of vasa previa: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2021;57:710–9. doi: 10.1002/uog.22166
doi: 10.1002/uog.22166
Green A, Chiu S, Manor E, Smith L, Oyelese Y. The association of gestational age at delivery with neonatal outcomes in prenatally diagnosed vasa previa. J Matern Fetal Neonatal Med 2022;35:10162–7. doi: 10.1080/14767058.2022.2122040
doi: 10.1080/14767058.2022.2122040
Mitchell SJ, Ngo G, Maurel KA, Hasegawa J, Arakaki T, Melcer Y, et al. Timing of birth and adverse pregnancy outcomes in cases of prenatally diagnosed vasa previa: a systematic review and meta-analysis. Am J Obstet Gynecol 2022;227:173–81.e24. doi: 10.1016/j.ajog.2022.03.006
doi: 10.1016/j.ajog.2022.03.006
Liu N, Hu Q, Liao H, Wang X, Yu H. Vasa previa: perinatal outcomes in singleton and multiple pregnancies. Biosci Trends 2021;15:118–25. doi: 10.5582/bst.2021.01052
doi: 10.5582/bst.2021.01052
Fishel Bartal M, Sibai BM, Ilan H, Katz S, Schushan Eisen I, Kassif E, et al. Prenatal diagnosis of vasa previa: outpatient versus inpatient management. Am J Perinatol 2019;36:422–7. doi: 10.1055/s-0038-1669396
doi: 10.1055/s-0038-1669396
Oyelese Y. Vasa previa: time to make a difference. Am J Obstet Gynecol 2019;221:539–41. doi: 10.1016/j.ajog.2019.08.034
doi: 10.1016/j.ajog.2019.08.034
Vintzileos AM, Ananth CV, Smulian JC. Using ultrasound in the clinical management of placental implantation abnormalities. Am J Obstet Gynecol 2015;213:S70–7. doi: 10.1016/j.ajog.2015.05.059
doi: 10.1016/j.ajog.2015.05.059
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting: Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group. JAMA 2000;283:2008–12. doi: 10.1001/jama.283.15.2008
doi: 10.1001/jama.283.15.2008
Chmait RH, Catanzarite V, Chon AH, Korst LM, Llanes A, Ouzounian JG. Fetoscopic laser ablation therapy for type II vasa previa. Fetal Diagn Ther 2020;47:682–8. doi: 10.1159/000508044
doi: 10.1159/000508044
Jauniaux E, Melcer Y, Maymon R. Prenatal diagnosis and management of vasa previa in twin pregnancies: a case series and systematic review. Am J Obstet Gynecol 2017;216:568–75. doi: 10.1016/j.ajog.2017.01.029
doi: 10.1016/j.ajog.2017.01.029
Westcott JM, Simpson S, Chasen S, Vieira L, Stone J, Doulaveris G, et al. Prenatally diagnosed vasa previa: association with adverse obstetrical and neonatal outcomes. Am J Obstet Gynecol MFM 2020;2:100206. doi: 10.1016/j.ajogmf.2020.100206
doi: 10.1016/j.ajogmf.2020.100206
Son M, Miller ES. Predicting preterm birth: cervical length and fetal fibronectin. Semin Perinatol 2017;41:445–51. doi: 10.1053/j.semperi.2017.08.002
doi: 10.1053/j.semperi.2017.08.002
Nohuz E, Boulay E, Gallot D, Lemery D, Vendittelli F. Can we perform a prenatal diagnosis of vasa previa to improve its obstetrical and neonatal outcomes? J Gynecol Obstet Hum Reprod 2017;46:373–7. doi: 10.1016/j.jogoh.2017.02.009
doi: 10.1016/j.jogoh.2017.02.009
Bronsteen R, Whitten A, Balasubramanian M, Lee W, Lorenz R, Redman M, et al. Vasa previa: clinical presentations, outcomes, and implications for management. Obstet Gynecol 2013;122:352–7. doi: 10.1097/AOG.0b013e31829cac58
doi: 10.1097/AOG.0b013e31829cac58
Zhang W, Geris S, Beta J, Ramadan G, Nicolaides KH, Akolekar R. Prevention of stillbirth: impact of two-stage screening for vasa previa. Ultrasound Obstet Gynecol 2020;55:605–12. doi: 10.1002/uog.21953
doi: 10.1002/uog.21953
Maymon R, Melcer Y, Tovbin J, Pekar-Zlotin M, Smorgick N, Jauniaux E. The rate of cervical length shortening in the management of vasa previa. J Ultrasound Med 2018;37:717–23. doi: 10.1002/jum.14411
doi: 10.1002/jum.14411
Swank ML, Garite TJ, Maurel K, Das A, Perlow JH, Combs CA, et al. Vasa previa: diagnosis and management. Am J Obstet Gynecol 2016;215:223.e1–6. doi: 10.1016/j.ajog.2016.02.044
doi: 10.1016/j.ajog.2016.02.044
Society of Maternal-Fetal Publications Committee, Sinkey RG, Odibo AO, Dashe JS. #37: Diagnosis and management of vasa previa. Am J Obstet Gynecol 2015;213:615–9. doi: 10.1016/j.ajog.2015.08.031
doi: 10.1016/j.ajog.2015.08.031
Catanzarite V, Cousins L, Daneshmand S, Schwendemann W, Casele H, Adamczak J, et al. Prenatally diagnosed vasa previa: a single-institution series of 96 cases. Obstet Gynecol 2016;128:1153–61. doi: 10.1097/AOG.0000000000001680
doi: 10.1097/AOG.0000000000001680
D'Souza R, Villani L, Hall C, Seyoum M, Kingdom J, Krznaric M, et al. Core Outcome Set for Studies on Pregnant Women With Vasa Previa (COVasP): a study protocol. BMJ Open 2020;10:e034018. doi: 10.1136/bmjopen-2019-034018
doi: 10.1136/bmjopen-2019-034018
Villani LA, Pavalagantharajah S, D'Souza R. Variations in reported outcomes in studies on vasa previa: a systematic review. Am J Obstet Gynecol MFM 2020;2:100116. doi: 10.1016/j.ajogmf.2020.100116
doi: 10.1016/j.ajogmf.2020.100116
Oyelese Y, Catanzarite V, Prefumo F, Lashley S, Schachter M, Tovbin Y, et al. Vasa previa: the impact of prenatal diagnosis on outcomes. Obstet Gynecol 2004;103:937–42. doi: 10.1097/01.AOG.0000123245.48645.98
doi: 10.1097/01.AOG.0000123245.48645.98
Baulies S, Maiz N, Munoz A, Torrents M, Echevarria M, Serra B. Prenatal ultrasound diagnosis of vasa praevia and analysis of risk factors. Prenat Diagn 2007;27:595–9. doi: 10.1002/pd.1753
doi: 10.1002/pd.1753
Degirmenci Y, Steetskamp J, Macchiella D, Hasenburg A, Hasenburg A. Vasa previa: a rare obstetric complication—a case series and a literature review. Clin Case Rep 2021;10:1–10. doi: 10.1002/ccr3.5608
doi: 10.1002/ccr3.5608
Erfani H, Haeri S, Shainker SA, Saad AF, Ruano R, et al. Vasa previa: a multicenter retrospective cohort study. Am J Obstet Gynecol 2019;221:644.e1-5. doi: 10.1016/j.ajog.2019.06.006
doi: 10.1016/j.ajog.2019.06.006
Francois K, Mayer S, Harris C, Perlow JH. Association of vasa previa at delivery with a history of second-trimester placenta previa. J Reprod Med 2003;48:771–4.
Golic M, Hinkson L, Bamberg C, Rodekamp E, Brauer M, Sarioglu N, et al. Vasa praevia: risk-adapted modification of the conventional management—a retrospective study. Ultraschall Med 2013;34:368–76. doi: 10.1055/s-0032-1313167
doi: 10.1055/s-0032-1313167
Gross A, Markota Ajd B, Specht C, Scheier M. Systematic screening for vasa previa at the 20-week anomaly scan. Acta Obstet Gynecol Scand 2021;100:1694–9. doi: 10.1111/aogs.14205
doi: 10.1111/aogs.14205
Hasegawa J, Farina A, Nakamura M, Matsuoka R, Ichizuka K, Sekizawa A, et al. Analysis of the ultrasonographic findings predictive of vasa previa. Prenat Diagn 2010;30:1121–5. doi: 10.1002/pd.2618
doi: 10.1002/pd.2618
Isotton AL, Salazar CC, Peralta CFA, Abdalla JML, Vettorazzi J. In Vitro fertilization and vasa previa: a report of two cases. Rev Bras Ginecol Obstet 2019;41:348–51. doi: 10.1055/s-0039-1683354
doi: 10.1055/s-0039-1683354
Kanda E, Matsuda Y, Kamitomo M, Maeda T, Mihara K, Hatae M. Prenatal diagnosis and management of vasa previa: a 6-year review. J Obstet Gynaecol Res 2011;37:1391–6. doi: 10.1111/j.1447-0756.2011.01544.x
doi: 10.1111/j.1447-0756.2011.01544.x
Kulkarni A, Powel J, Aziz M, Shah L, Lashley S, Benito C, et al. Vasa previa: prenatal diagnosis and outcomes: thirty-five cases from a single maternal-fetal medicine practice. J Ultrasound Med 2018;37:1017–24. doi: 10.1002/jum.14452
doi: 10.1002/jum.14452
Lee W, Lee VL, Kirk JS, Sloan CT, Smith RS, Comstock CH. Vasa previa: prenatal diagnosis, natural evolution, and clinical outcome. Obstet Gynecol 2000;95:572–6. doi: 10.1016/s0029-7844(99)00600-6
doi: 10.1016/s0029-7844(99)00600-6
Mabuchi Y, Yamoto M, Minami S, Boshi E, Yagi S, Oba N, et al. Two cases of vasa previa diagnosed prenatally using three-dimensional ultrasonography. J Clin Ultrasound 2010;38:389–92. doi: 10.1002/jcu.20722
doi: 10.1002/jcu.20722
Rebarber A, Dolin C, Fox NS, Klauser CK, Saltzman DH, Roman AS. Natural history of vasa previa across gestation using a screening protocol. J Ultrasound Med 2014;33:141–7. doi: 10.7863/ultra.33.1.141
doi: 10.7863/ultra.33.1.141
Smorgick N, Tovbin Y, Ushakov F, Vaknin Z, Barzilay B, Herman A, et al. Is neonatal risk from vasa previa preventable? The 20-year experience from a single medical center. J Clin Ultrasound 2010;38:118–22. doi: 10.1002/jcu.20665
doi: 10.1002/jcu.20665
Sullivan EA, Javid N, Duncombe G, Li Z, Safi N, Cincotta R, et al. Vasa previa diagnosis, clinical practice, and outcomes in Australia. Obstet Gynecol 2017;130:591–8. doi: 10.1097/AOG.0000000000002198
doi: 10.1097/AOG.0000000000002198
Sutera M, Garofalo A, Pilloni E, Parisi S, Alemanno MG, Menato G, et al. Vasa previa: when antenatal diagnosis can change fetal prognosis. J Perinat Med 2021;49:915–22. doi: 10.1515/jpm-2020-0559
doi: 10.1515/jpm-2020-0559
Tachibana D, Misugi T, Pooh RK, Kitada K, Kurihara Y, Tahara M, et al. Placental types and effective perinatal management of vasa previa: lessons from 55 cases in a single institution. Diagnostics (Basel) 2021;11:1369. doi: 10.3390/diagnostics11081369
doi: 10.3390/diagnostics11081369
Wiafe YA, Adu-Bredu TK, Appiah-Denkyira K, Senaya CM. Antenatal diagnosis of vasa previa: report of three cases in an African setting. Pan Afr Med J 2020;37:24. doi: 10.11604/pamj.2020.37.24.25663
doi: 10.11604/pamj.2020.37.24.25663
Yerlikaya-Schatten G, Chalubinski KM, Pils S, Springer S, Ott J. Risk-adapted management for vasa praevia: a retrospective study about individualized timing of caesarean section. Arch Gynecol Obstet 2019;299:1545–50. doi: 10.1007/s00404-019-05125-9
doi: 10.1007/s00404-019-05125-9

Auteurs

Kent Heyborne (K)

Denver Health Medical Center and the University of Colorado School of Medicine, Aurora, Colorado.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH